Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Co-founder & CEO
Jonathan Ward has more than 20 years experience in preclinical R&D and toxicology testing. Jonathan was the COO at PWG Genetics (preclinical CRO) and Bioresearch Manager and Principal Scientist at Philip Morris International (leading toxicology studies as Test Facility Manager).
Co-founder & CTO
Prof. Jaya Krishnan has more than 20 years experience in preclinical models and cardiovascular disease research. He completed his PhD at Imperial College London and led research at the ETH-Zurich, Medical Research Council UK and Imperial College London. He currently leads an RNA Therapeutics group in Germany.
Co-founder & Head of Development
Duc Minh Pham has more than 10 years of experience in assay development, human pluripotent stem cells and organoid culture in Albert-Ludwigs University Hospital Freiburg and Goethe University Hospital Frankfurt. His work is focused on generating/validating heart and lung organoid models for biomedical research, and drug discovery and development.
Chief Operating Officer
Dr. Maria Duda joins Genome Biologics from Management Consulting company ZS Associates where she assessed and developed strategies in the area of key account management and launch planning for top pharmaceutical clients. Prior to career in Management Consulting, Maria led a multi-disciplinary project at Medical Research Council UK aimed at understanding the mechanical underpinnings of disease. Maria received her scientific training from ETH Zurich, where she obtained her PhD in novel therapeutic approaches for kidney cancer.